A Phase 2, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 Weeks in Subjects with Chronic HCV Infection and Child-Pugh-Turcotte Class Cirrhosis
Clinical Trial Grant
Administered By
Medicine, Gastroenterology
Awarded By
Gilead Sciences, Inc.
Start Date
March 20, 2017
End Date
April 30, 2019
Administered By
Medicine, Gastroenterology
Awarded By
Gilead Sciences, Inc.
Start Date
March 20, 2017
End Date
April 30, 2019